These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 1196134

  • 1. Effects of 1alpha-hydroxy-vitamin D3 and 1,25-dihydroxy-vitamin D3 on calcium and phosphorus metabolism in hypoparathyroidism.
    Neer RM, Holick MF, DeLuca HF, Potts JT.
    Metabolism; 1975 Dec; 24(12):1403-13. PubMed ID: 1196134
    [Abstract] [Full Text] [Related]

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 3. Comparison of effects of 1 alpha-hydroxy-vitamin D3 and 1,25-dihydroxy-vitamin D3 in man.
    Brickman AS, Coburn JW, Friedman GR, Okamura WH, Massry SG, Norman AW.
    J Clin Invest; 1976 Jun; 57(6):1540-7. PubMed ID: 932193
    [Abstract] [Full Text] [Related]

  • 4. Recent advances in our understanding of the vitamin D endocrine system.
    De Luca HF.
    J Lab Clin Med; 1976 Jan; 87(1):7-26. PubMed ID: 173767
    [Abstract] [Full Text] [Related]

  • 5. Effects of 1alpha,25-dihydroxyvitamin D3 and Solanum glaucophyllum on intestinal calcium and phosphate transport and on plasma Ca, Mg and P levels in the rat.
    Walling MW, Kimberg DV.
    Endocrinology; 1975 Dec; 97(6):1567-76. PubMed ID: 1204578
    [Abstract] [Full Text] [Related]

  • 6. Vitamin D: the discovery of its metabolites and their therapeutic applications.
    Beale MG, Chan JC, Oldham SB, Deluca HF.
    Pediatrics; 1976 May; 57(5):729-41. PubMed ID: 181725
    [Abstract] [Full Text] [Related]

  • 7. Vitamin D metabolites and bone mineralization in man.
    Bordier P, Rasmussen H, Marie P, Miravet L, Gueris J, Ryckwaert A.
    J Clin Endocrinol Metab; 1978 Feb; 46(2):284-94. PubMed ID: 750606
    [Abstract] [Full Text] [Related]

  • 8. Acute actions of 1,25-dihydroxy-vitamin D3 in normal man: effect on calcium and parathyroid status.
    Llach F, Coburn JW, Brickman AS, Kurokawa K, Norman AW, Canterbury JM, Reiss E.
    J Clin Endocrinol Metab; 1977 Jun; 44(6):1054-60. PubMed ID: 194908
    [Abstract] [Full Text] [Related]

  • 9. Metabolism of vitamin D: current status.
    DeLuca HF.
    Am J Clin Nutr; 1976 Nov; 29(11):1258-70. PubMed ID: 187053
    [Abstract] [Full Text] [Related]

  • 10. Effect of hydrochlorothiazide on 1,25-dihydroxyvitamin D3-induced changes in calcium metabolism in experimental hypoparathyroidism in rats.
    Rizzoli R, Hugi K, Fleisch H, Bonjour JP.
    Clin Sci (Lond); 1981 Jan; 60(1):101-7. PubMed ID: 6894567
    [Abstract] [Full Text] [Related]

  • 11. Comparison of acute effects of 1.25- and 24.25-dihydroxy-vitamin D3 in normal subjects.
    Heynen G, Cornet F, Franchimont P, Gaspar S, Plomteux G, Cession-Fossion G, Russel RG, Kanis JA.
    Acta Endocrinol (Copenh); 1981 Dec; 98(4):619-24. PubMed ID: 6975547
    [Abstract] [Full Text] [Related]

  • 12. Effect of 1alpha-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 on intestine and bone in glucocorticoid-treated patients.
    Lund B, Andersen RB, Friis T, Hjorth L, Jørgensen FS, Norman AW, Sørensen OH.
    Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():177s-181s. PubMed ID: 606415
    [Abstract] [Full Text] [Related]

  • 13. The kidney as an endocrine organ involved in the function of vitamin D.
    DeLuca HF.
    Am J Med; 1975 Jan; 58(1):39-47. PubMed ID: 163578
    [Abstract] [Full Text] [Related]

  • 14. Vitamin D-resistant rickets. A prototype of nutritional management of a genetic disorder.
    Deluca HF.
    Curr Concepts Nutr; 1979 Jan; 8():3-32. PubMed ID: 230941
    [Abstract] [Full Text] [Related]

  • 15. Effect of 25-hydroxy-vitamin D3 on intestinal absorption of calcium in normal man and patients with renal failure.
    Colodro IH, Brickman AS, Coburn JW, Osborn TW, Norman AW.
    Metabolism; 1978 Jun; 27(6):745-53. PubMed ID: 651659
    [Abstract] [Full Text] [Related]

  • 16. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V, Torregrosa V.
    Nefrologia; 2008 Jun; 28 Suppl 3():67-78. PubMed ID: 19018742
    [Abstract] [Full Text] [Related]

  • 17. 1,25-dihydroxyvitamin D3 and 1, alpha-hydroxyvitamin D3 in children: biologic and therapeutic effects in nutritional rickets and different types of vitamin D resistance.
    Balsan S, Garabedian M, Sorgniard R, Holick MF, Deluca HF.
    Pediatr Res; 1975 Jul; 9(7):586-93. PubMed ID: 169507
    [Abstract] [Full Text] [Related]

  • 18. Relative effectiveness of vitamin D metabolites in increasing bone mineral solubility.
    Somerman MJ, Neuman WF.
    Calcif Tissue Int; 1981 Jul; 33(2):159-65. PubMed ID: 6783272
    [Abstract] [Full Text] [Related]

  • 19. Effect of vitamin D treatment in hypoparathyroid patients: a study on calcium, phosphate and magnesium homeostasis.
    Mortensen L, Hyldstrup L, Charles P.
    Eur J Endocrinol; 1997 Jan; 136(1):52-60. PubMed ID: 9037127
    [Abstract] [Full Text] [Related]

  • 20. 1alpha-hydroxycholecalciferol in the treatment of hypoparathyroidism.
    Jorgensen H, Vogt JH.
    Acta Med Scand; 1977 Jan; 201(1-2):3-7. PubMed ID: 835368
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.